Sociedad Americana de Hirudoterapia

A Systematic Review of Complementary and Alternative Veterinary Medicine: Miscellaneous Therapies

Bergh A, Lund I, Boström A, Hyytiäinen H, Asplund K (2021) · Animals · n=42

Detalle de evidencia de RCTReferencia del ensayo
GRADE bajaCohorte / serie de casos
Tamaño de muestra de este ensayo en comparación con otros ensayos de venous-congestion-flapMarquard JM 20251215Bishop JL 2023843Doğan S 2024570Troeltzsch M 2016330Kucur C 2015260Wang ZD 2022210Lehnhardt M 202196Kruer RM 201459Mozafari N 201056Bergh A 202142
Este ensayo (destacado) por tamaño de muestra junto a otros ensayos indexados de venous-congestion-flap. Los ensayos más grandes generalmente tienen mayor peso estadístico.

Perfil del estudio

Diseño
PRISMA-compliant systematic review of complementary and alternative veterinary medicine (CAVM) therapies including leech therapy (hirudotherapy) in cats, dogs, and horses; Web of Science / CABI / PubMed search (Swedish University of Agricultural Sciences, Karolinska, University of Helsinki, Umeå University)
Tamaño de la muestra (n)
42
Intervención
Veterinary leech therapy (hirudotherapy) examined among 24 CAVM modalities for cats, dogs, and horses; 42 studies eligible across all CAVM modalities, of which 9 categories had any evidence including leech therapy
Comparador
Standard veterinary care or untreated control (across heterogeneous included trials)
Punto final primario
Strength of clinical evidence for each CAVM therapy in companion animals and horses
Resultado primario
42 studies across nine identified CAVM modalities (aromatherapy, gold therapy, homeopathy, hirudotherapy, mesotherapy, mud, neural therapy, sound/music therapy, vibration therapy); 15 of 24 predefined therapies had no studies; bias risk high in 17 studies, moderate-to-high in 10, moderate in 10, low-to-moderate in 4, low in 1; even among lower-bias studies, considerable heterogeneity in treatment effects; authors conclude scientific evidence insufficient to define clinical efficacy of the reviewed CAVM therapies including leech therapy
Duración del seguimiento
Variable across included studies

Hallazgos clave

  • First multi-modal systematic review including veterinary hirudotherapy in cats/dogs/horses
  • High overall risk of bias across included veterinary CAVM studies
  • Veterinary leech-therapy clinical evidence base remains thin
  • Authors call for higher-quality veterinary RCTs
  • Important context for cross-species ASH safety and ethics literature

Limitaciones

  • Mixed indication and species — no condition-specific synthesis
  • High bias-risk dominates the underlying veterinary studies
  • Pre-2021 literature only — may miss recent veterinary case series
  • English-language search may have missed veterinary literature in other languages
  • Authors do not separate leech-specific evidence from other CAVM modalities

Implicaciones clínicas

Bergh 2021 confirms that veterinary hirudotherapy remains an under-evidenced practice area. For ASH's broader scientific scope, the review provides cross-species context (alongside Trenholme 2021 leech-induced airway obstruction veterinary case) and reinforces the need for higher-quality veterinary trials before clinical recommendations can be extended to companion-animal or equine practice. No US K040187 device-clinical-practice implications.

Estudios relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.